Better Obesity Drug Race: Novo Nordisk vs Lilly 2026
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
Where do index funds fit in a diversified portfolio? They serve as core ballast in equity exposure, balancing concentration risk from individual securities.
21,874 articlesIn the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
In 2026, investors face a choice between a pure digital disruptor in LatAm and a large US consumer lender with a heav...
NRG Energy announced a transformative deal that doubles its generation capacity to roughly 25 GW and targets 14% annu...
The Virtus InfraCap U.S. Preferred Stock ETF trades near $21 with a 9.9% forward yield built on leverage and high-cou...
As 2026 approaches, the investment narrative around quantum computing is shifting. This in-depth look explains why th...
Upwork stock has fallen this year as a big investor sold a multi-million stake, raising questions about the company’s...
Investing in space-related stocks can be thrilling and risky. This article lays out two crucial things every rocket i...
Greg Abel has stepped into Berkshire Hathaway’s top role with a plan that blends steady operations with a measured ap...
As data centers expand and AI workloads surge, a handful of tech leaders stand out as potential monster stocks hold n...
Kevin O’Leary’s $4.2 billion Softkey exit in 1999 turned him into a millionaire, but the moment was surprisingly low-...
IonQ just posted revenue that more than tripled for the third straight quarter, but the stock sold off despite the ga...
When a hedge fund makes a substantive move in Genpact, it prompts investors to reassess the stock. This article break...